We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AVE.AU

Price
0.01
Stock movement up
+- (%)
Company name
Avecho Biotechnology Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
15.85M
Ent value
12.66M
Price/Sales
20.17
Price/Book
3.76
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-9.71%
1 year return
25.00%
3 year return
-29.05%
5 year return
4.56%
10 year return
-24.49%
Last updated: 2025-04-12

DIVIDENDS

AVE.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales20.17
Price to Book3.76
EV to Sales16.11

FINANCIALS

Per share

Loading...
Per share data
Current share count3.17B
EPS (TTM)-0.00
FCF per share (TTM)-0.00

Income statement

Loading...
Income statement data
Revenue (TTM)785.74K
Gross profit (TTM)-15.29K
Operating income (TTM)-7.48M
Net income (TTM)-5.61M
EPS (TTM)-0.00
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-1.95%
Operating margin (TTM)-952.48%
Profit margin (TTM)-714.21%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash4.84M
Net receivables549.33K
Total current assets5.62M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets5.86M
Accounts payable975.19K
Short/Current long term debt137.41K
Total current liabilities1.59M
Total liabilities1.65M
Shareholder's equity4.22M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-4.01M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-4.01M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-133.09%
Return on Assets-95.69%
Return on Invested Capital-130.60%
Cash Return on Invested Capital-93.29%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.00
Daily high0.01
Daily low0.00
Daily Volume416K
All-time high0.87
1y analyst estimate1.72
Beta2.12
EPS (TTM)-0.00
Dividend per share-
Ex-div date22 Sep 2010
Next earnings date30 May 2025

Downside potential

Loading...
Downside potential data
AVE.AUS&P500
Current price drop from All-time high-99.43%-12.89%
Highest price drop-99.77%-56.47%
Date of highest drop13 Jan 20259 Mar 2009
Avg drop from high-80.08%-11.07%
Avg time to new high155 days12 days
Max time to new high6797 days1805 days
COMPANY DETAILS
AVE.AU (Avecho Biotechnology Ltd) company logo
Marketcap
15.85M
Marketcap category
Small-cap
Description
Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found